{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-092999","form_type":"8-K","ticker":"ACH","cik":"0000075252","company_name":"ACCENDRA HEALTH INC/VA/","filed_at":"2026-08-10T10:50:13+00:00","discovered_at":"2026-08-10T10:55:00.290415+00:00","generated_at":"2026-08-10T10:55:21.892637+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Accendra Health Q2 revenue down 10%, adjusted loss; CEO Pesicka to retire by end of 2026","bullets":["Q2 net revenue $613.2M, down 10% YoY from $681.9M; GAAP EPS -$1.16 vs -$1.09.","Adjusted EBITDA $60.1M vs $96.6M; adjusted EPS -$0.19 vs +$0.26; free cash flow -$25.1M.","Reduced total debt by $385M in Q2 via balance sheet optimization closed in June.","CEO Ed Pesicka to retire by end of 2026; will step down from Board; succession process underway.","Eliminated over $125M annualized operating expense from large commercial payor exit."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-092999","json":"https://secwatch.observer/filing/0001104659-26-092999.json","markdown":"https://secwatch.observer/filing/0001104659-26-092999.md","text":"https://secwatch.observer/filing/0001104659-26-092999.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/75252/000110465926092999/0001104659-26-092999-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/75252/000110465926092999/tm2622667d2_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-10T10:55:21.892637+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}